08 December 2022 MDS colleagues celebrate receiving MRC clinical fellowships Two University of Birmingham researchers have been awarded prestigious Medical Research Council (MRC) clinical fellowships this year.
08 December 2022 University of Birmingham announces all language capability for tool to expedite Long COVID research The validated Symptom Burden Questionnaire™ for Long COVID (SBQ™-LC) will help medical researchers develop or test new treatments.
05 December 2022 New device from Birmingham, U.K., to provide early diagnosis for cardiac tamponade Diagnostic device to monitor against post-surgery heart strangulation risk under development by company formed by Birmingham cardiothoracic surgeon
02 December 2022 Abnormal heartbeat identified in 1 in 20 older adults using wrist-worn wearable and smartphone A new study, conducted by the Atrial Fibrillation NETwork (AFNET), offered smartphone and arrhythmia screening to older adults without atrial fibrillation.
01 December 2022 Immune T cell defence is coping with COVID-19 variants of concern – for now Broad T-cell response is currently protective but recognition of seven out of ten T-cell targets mutated in SARS-CoV-2 variants is impaired
23 November 2022 World’s first clinical trial to test new drug glenzocimab for heart attacks New partnership with Acticor Biotech will see patients with heart attacks treated with glenzocimab, a promising new class of drug for the first time.
21 November 2022 ‘Playbook’ sets out ways to fight back against antimicrobial resistance ‘Resistance breakers’ and better genetic tests are among new ways that scientists could address antimicrobial resistance, a new paper suggests.
16 November 2022 Inflammation and Ageing Research Fellow receives £1.2M Competitive MRC Career Development Fellowship Dr Jon Hazeldine, Research Fellow at the University of Birmingham, has been awarded a competitive MRC Career Development Award Fellowship totalling £1.2M.
15 November 2022 Researchers make miniature ‘bone marrows in a dish’ to improve anti-cancer treatments The organoids provide a micro-environment that can accept and support the survival of cells from patients with blood malignancies
14 November 2022 New UK-first trial to screen 20,000 children for type 1 diabetes Blood tests will identify children likely to develop type 1 diabetes, allowing earlier, safer diagnosis
14 November 2022 Childhood maltreatment linked with higher risk of asthma and atopic disease UK analysis raises need for awareness of health implications for patients following abuse and neglect
11 November 2022 Historic concussion monitoring collaboration extended during Women’s 2021 Rugby World Cup The collaboration between University of Birmingham spin-off Marker Diagnostics, Rugby Football Union and World Rugby extended for the Women’s Rugby World Cup